- view fewer
Evidence of admixture from haplotyping in an epidemiological study of UK Caucasian males: Implications for association analyses.
142 - 155.
Objective: Cohort and case-control genetic association studies offer the greatest power to detect small genotypic influences on disease phenotypes, relative to family-based designs. However, genetic subdivisions could confound studies involving unrelated individuals, but the topic has been little investigated. We examined geographical and interallelic association of SNP and microsatellite haplotypes of the Y chromosome, of regions of chromosome 11, and of autosomal SNP genotypes relevant to cardiovascular risk traits in a UK-wide epidemiological survey. Results: We show evidence (p = 0.00001) of the Danelaw history of the UK, marked by a two-fold excess of a Viking Y haplotype in central England. We also found evidence for a (different) single-centre geographical over-representation of one haplotype, both for APOC3-A4-A5 and for IGF2. The basis of this remains obscure but neither reflect genotyping error nor correlate with the phenotypic associations by centre of these markers. A panel of SNPs relevant to cardiovascular risks traits showed neither association with geographical location nor with Y haplotypes. Conclusion: Combinations of Y haplotyping, autosomal haplotyping, and genome-wide SNP typing, taken together with phenotypic2 associations, should improve epidemiological recognition and interpretation of possible confounding by genetic subdivision. Copyright (C) 2004 S. Karger AG, Basel.
|Title:||Evidence of admixture from haplotyping in an epidemiological study of UK Caucasian males: Implications for association analyses|
|Keywords:||genetic association studies, population subdivision, stratification, Y chromosome, autosomal SNPs, haplotypic analysis, SINGLE-NUCLEOTIDE POLYMORPHISMS, CORONARY-HEART-DISEASE, DIAGONAL GEL-ELECTROPHORESIS, POPULATION STRATIFICATION, FAMILIAL HYPERCHOLESTEROLEMIA, LINKAGE-DISEQUILIBRIUM, ALLELIC ASSOCIATION, GENETIC ASSOCIATION, MUTATION, HEMOCHROMATOSIS|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science|
Archive Staff Only